Modified amino acid for the inhibition of platelet aggregation -> Monitor Keywords
Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
site info Site News  |  monitor Monitor Keywords  |  monitor archive Monitor Archive  |  organizer Organizer  |  account info Account Info  |  
11/13/08 - USPTO Class 514 |  1 views | #20080280817 | Prev - Next | About this Page  514 rss/xml feed  monitor keywords

Modified amino acid for the inhibition of platelet aggregation

Title: Modified amino acid for the inhibition of platelet aggregation




Brief Patent Description - Full Patent Description - Patent Claims

The Patent Description & Claims data below is from USPTO Patent Application 20080280817, Modified amino acid for the inhibition of platelet aggregation.


1: A method of inhibiting platelet aggregation in a mammal comprising administering to said mammal a pharmaceutical composition comprising a modified amino acid, or a pharmaceutically acceptable salt thereof.

2: The method according to claim 1, wherein the pharmaceutical composition additionally comprises a pharmacologically active agents, and wherein the modified amino acid or salt thereof is present in an amount effective to inhibit platelet aggregation.

3: The method according to claim 1, wherein the modified amino acid is N-(−5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC).

4: The method according to claim 2, wherein the pharmacologically active agent comprises heparin, insulin, parathyroid hormone or calcitonin.

5: The method according to claim 4, wherein the mammal is human and the calcitonin is salmon calcitonin.

6: The method according to claim 1 wherein the modified amino acid or pharmaceutically acceptable salt thereof is present in an amount of about 25 mg to about 400 mg.

7: The method according to claim 6, wherein the modified amino acid or pharmaceutically acceptable salt thereof is present in an amount of about 100 mg to about 200 mg.

8: The method according to claim 2, wherein the pharmacologically active agent is present in an amount of 0.05% to 70% by weight relative to the total weight of the pharmaceutical composition.

9: The method according to claim 2, wherein the pharmaceutical composition comprises calcitonin and 5-CNAC or a pharmaceutically acceptable salt thereof.

10: A pharmaceutical composition comprising a platelet aggregation inhibiting amount of a modified amino acid, or a pharmaceutically acceptable salt thereof.

11: The pharmaceutical composition according to claim 10, further comprising a pharmacologically active agent, wherein the modified amino acid or salt thereof is present in an amount effective to inhibit platelet aggregation.

12-

13. (canceled)

Brief Patent Description - Full Patent Description - Patent Claims

Click on the above for other options relating to this Modified amino acid for the inhibition of platelet aggregation patent application.
###
monitor keywords

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Modified amino acid for the inhibition of platelet aggregation or other areas of interest.
###


Previous Patent Application:
Methods and pharmaceutical compositions for healing wounds
Next Patent Application:
Pharmaceutical compositions containing insulin and insulinotropic peptide
Industry Class:
Drug, bio-affecting and body treating compositions

###

FreshPatents.com Support
Thank you for viewing the Modified amino acid for the inhibition of platelet aggregation patent info.
IP-related news and info


Results in 0.08647 seconds


Other interesting Feshpatents.com categories:
Accenture , Agouron Pharmaceuticals , Amgen , AT&T , Bausch & Lomb , Callaway Golf 174
filepatents (1K)

* Protect your Inventions
* US Patent Office filing
patentexpress PATENT INFO